There have been many studies that have been conducted in order to ascertain the relationship between the impact of the residual beta cells and the functioning of the glycerine content on controlling diabetes type 1. There have been various studies that have been conducted so far by taking a sample of the population which has nearly 30 participants. They are all the persons who contain the amount of diabetes which is probably less than the time period of 3 years. The results of these studies have concluded that the CGM parameters were comparable across various groups especially during the observation session. The group which had a higher content of glucose active was the one which had a higher number of residual beta cells in him or her. Any change in the CGM outcomes from pre-exercise to 24-hour post-exercise was very divergent. Therefore, it was concluded that the residual beta cells are partially helpful in curing the patients who have been diagnosed with type one of diabetes. There has been additional evidence to report this fact. The quantification of C peptide could also be helpful in providing personalized support to the people affected by the same.
Ref art: https://care.diabetesjournals.org/content/43/10/2362
